Approvals/TGA/EZETIMIBE - ROSUVASTATIN SANDOZ 10 MG / 5 MG ezetimibe 10 mg tablets and rosuvastatin (as calcium) 5 mg tablets composite pack

Approved

STANDARD

EZETIMIBE - ROSUVASTATIN SANDOZ 10 MG / 5 MG ezetimibe 10 mg tablets and rosuvastatin (as calcium) 5 mg tablets composite pack

Sandoz Pty Ltd🇦🇺 Therapeutic Goods Administration

Approval Id: a252a8bd135514c1
Product Name: EZETIMIBE - ROSUVASTATIN SANDOZ 10 MG / 5 MG ezetimibe 10 mg tablets and rosuvastatin (as calcium) 5 mg tablets composite pack
Artg Id: 318875
Artg Name: EZETIMIBE - ROSUVASTATIN SANDOZ 10 MG / 5 MG ezetimibe 10 mg tablets and rosuvastatin (as calcium) 5 mg tablets composite pack
Sponsor: Sandoz Pty Ltd
Company Detail Path: /organization/sandoz-pty-ltd
Artg Date: 2022-07-07
Registration Type: Medicine
Therapeutic Good Type: Medicine
Licence Status: A
Licence Category: RE
Consumer Medicine Info: http://www.ebs.tga.gov.au/ebs/picmi/picmirepository.nsf/pdf?OpenAgent=&id=CP-2025-CMI-01245-1
Product Information: http://www.ebs.tga.gov.au/ebs/picmi/picmirepository.nsf/pdf?OpenAgent=&id=CP-2022-PI-01795-1

Approved

Agency

TGA

Country

🇦🇺

Approval Date

Dec 9, 2025

Approval ID

a252a8bd135514c1

Type

Standard